Registered number: 10746238

Pharmekon Ltd
Unaudited Financial Statements
for the year ended 30 April 2024

Statement of Financial Position

as at 30 April 2024

  2024
2023
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  667  
 
  699  
Current assets  
110,488    
 
172,295    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
( 2,716 )  
 
( 16,317 )  
Net current assets (liabilities)  
  107,772  
 
  155,978  
Total assets less current liabilities  
  108,439  
 
  156,677  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  108,439  
 
  156,677  
   
Capital and reserves  
  108,439  
 
  156,677  

xbrli:pure 10746238 2023-05-01 2024-04-30 10746238 2022-05-01 2023-04-30 10746238 2024-04-30 10746238 2023-04-30 10746238 2023-05-01 10746238 uk-frs102:WithinOneYear 2024-04-30 10746238 uk-frs102:AfterOneYear 2024-04-30 10746238 uk-frs102:WithinOneYear 2023-04-30 10746238 uk-frs102:AfterOneYear 2023-04-30 10746238 uk-bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 10746238 uk-bus:FilletedAccounts 2023-05-01 2024-04-30 10746238 uk-bus:Director1 1 2023-05-01 2024-04-30 10746238 uk-bus:Director1 2023-05-01 2024-04-30 10746238 uk-bus:Director1 1 2023-05-01 10746238 uk-bus:Director1 1 2024-04-30 10746238 uk-bus:Micro-entities 2023-05-01 2024-04-30 10746238 uk-bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 iso4217:GBP 10746238 countries:EnglandWales 2023-05-01 2024-04-30 10746238 uk-bus:RegisteredOffice 2023-05-01 2024-04-30

Footnotes to the Statement of Financial Position

Sophia Marsh

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

The Director Sophia Marsh, has no amount owing to the company at the opening or closing date of the Statement of Financial Position.

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the year ending 30/04/2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 10746238

c) The company is a private company and is limited by shares

d) The company's registered office address is W8a Knoll Business Centre 325-327 Old Shoreham Road, Hove, BN3 7GS, England



Approved by the board of directors and signed on behalf of the board,

Pharmekon Ltd
Director Sophia Marsh
Date of approval: 30/10/2024
The company was trading for the entire period 2023-05-01 2024-04-30 2024-04-30 Pharmaceutical industry 2024-10-30 2024-10-30